QIAGEN NV's ticker is QGENXXXX and the CUSIP is N72482107. A total of 164 filers reported holding QIAGEN NV in Q4 2013. The put-call ratio across all filers is 0.33 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2014 | $346,000 | +3.3% | 14,730 | 0.0% | 0.01% | 0.0% |
Q3 2014 | $335,000 | -6.2% | 14,730 | +0.9% | 0.01% | 0.0% |
Q2 2014 | $357,000 | +19.0% | 14,600 | +2.7% | 0.01% | +16.7% |
Q1 2014 | $300,000 | -12.0% | 14,215 | -0.7% | 0.01% | -14.3% |
Q4 2013 | $341,000 | -5.5% | 14,315 | -15.1% | 0.01% | 0.0% |
Q3 2013 | $361,000 | -14.3% | 16,865 | -20.3% | 0.01% | -22.2% |
Q2 2013 | $421,000 | – | 21,165 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Hardman Johnston Global Advisors LLC | 6,178,402 | $170,833,000 | 11.32% |
Tikvah Management LLC | 369,425 | $10,215,000 | 5.35% |
BLUE JAY CAPITAL MANAGEMENT, LLC | 360,000 | $9,954,000 | 3.36% |
Opus Point Partners Management, LLC | 160,000 | $4,424,000 | 2.92% |
Exane Asset Management | 106,238 | $2,910,304,000 | 1.76% |
Douglas C. Lane & Associates, Inc. | 1,918,338 | $53,042,000 | 1.44% |
Granahan Investment Management | 1,051,000 | $29,060,000 | 1.00% |
CRAMER ROSENTHAL MCGLYNN LLC | 2,285,569 | $63,196,000 | 0.95% |
Sivik Global Healthcare LLC | 70,000 | $1,936,000 | 0.92% |
PURA VIDA INVESTMENTS, LLC | 78,668 | $2,175,000 | 0.92% |